+ 164% at the close. Not bad for a nasdaq stock :-)))
Maybe it is on the news:
MedCare Technologies, Inc. Announces RxSheets.com Receives Strong Response from Physicians
OAK BROOK, Ill., Nov 23, 1999 (BUSINESS WIRE) -- MedCare
Tech(NASDAQ: MCAR)
MedCare Technologies, Inc. (NASDAQ: MCAR) announced today that its
online business, RxSheets.com (www.rxsheets.com), has received
overwhelming response from physicians throughout the country. The
Company launched its pharmaceutical focused site for physicians in
October and began its marketing campaign on November 15th. During the
first five days, the Company received thousands of physician requests
to enroll in its program every day.
"The response from the medical community has been tremendous," said
Jeff Aronin, President and Chief Executive Officer. "RxSheets.com will
revolutionize the way doctors across the country will request their
pharmaceutical samples. This is the best online product that caters to
the physician's pharmaceutical needs by providing an easy alternative
to request and deliver samples in a prompt manner. In addition, the
site delivers timely concise industry related information. Unlike all
the other physician-focused sites, Rxsheets has the ability to get
physicians online and using the site. Based on the multi-billion dollar
value of the physician marketplace to pharmaceutical and medical
companies, we believe Rxsheets can be an extremely profitable and
lucrative business. We are not aware of any physician site that has
received the excitement and response from the physician community."
Exclusively designed for the physician, RxSheets.com offers a wide
array of compelling and focused information and services, including
drug sample requests, drug protocols and studies, research information
and other pertinent aspects of the pharmaceutical market.
The site will also offer a healthcare calendar of events, educational
opportunities and a weekly pharmaceutical newsletter.
MedCare Technologies, Inc. is a healthcare technology service company
that focuses on under-served high growth markets. The Company's
RxSheets.com (www.rxsheets.com), offers a wide array of compelling and
focused information and services, including drug sample requests for
physicians, drug protocols and studies, research information, and other
pertinent aspects of the $270 billion worldwide pharmaceutical market.
The Company began by developing the MedCare Program, now the nations
leading conservative therapy for treating urinary incontinence, a
hidden health condition that, at approximately $26 billion, costs more
than diabetes and bypass surgery combined.
This news release contains forward-looking statements as defined by the
Private Securities Litigation Reform Act of 1995. Forward-looking
statements include statements concerning plans, objectives, goals,
strategies, future events or performance and underlying assumptions and
other statements which are other than statements of historical facts.
These statements are subject to uncertainties and risks including, but
not limited to, product and service demand and acceptance, changes in
technology, changes in insurance reimbursement, economic conditions,
the impact of competition and pricing, government regulation, and other
risks defined in this document and in statements filed from time to
time with the Securities and Exchange Commission. All such
forward-looking statements, whether written or oral, and whether made
by or on behalf of the Company are expressly qualified by these
cautionary statements and any other cautionary statements which may
accompany the forward-looking statements. In addition, the Company
disclaims any obligation to update any forward-looking statements to
reflect events or circumstances after the date hereof.
|
